# FDA 483 - Sanjeev Puri, Clinical Investigator - December 14, 2018

Source: https://www.globalkeysolutions.net/records/483/sanjeev-puri-clinical-investigator/c1e3092f-33f1-418c-8146-c72e82b18a06

> FDA 483 for Sanjeev Puri, Clinical Investigator on December 14, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sanjeev Puri, Clinical Investigator
- Inspection Date: 2018-12-14
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Sanjeev Puri, Clinical Investigator, in Rock Island, IL, revealed significant deficiencies in clinical trial conduct. The inspection found failures to maintain adequate case histories, specifically regarding physical examination documentation, and a lack of adherence to the investigational plan, including the failure to report adverse events for study subjects.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/corey-k-reno/f6ff7629-784b-467b-8b5b-2625779d1c1e)

Company: https://www.globalkeysolutions.net/companies/sanjeev-puri-clinical-investigator/f68b9984-ba0c-4861-8fb8-a6ce58ed379b

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d